HLA-G and neoplasm: JNJ-78306358 simultaneously binds to the α3 domain of HLA-G isoforms on tumor cells and to the CD3 receptor complex on T cells [12], mediating immune synapse formation and tumor cell killing by cytotoxic T cells, while mitigating the immunosuppressive tumor microenvironment [13].